{"id":12589,"date":"2023-09-16T15:00:27","date_gmt":"2023-09-16T15:00:27","guid":{"rendered":"https:\/\/prosfunds.com\/investing\/rayzebio-stock-opens-with-a-big-gain-to-push-valuation-up-to-1-4-billion\/"},"modified":"2023-09-16T15:00:27","modified_gmt":"2023-09-16T15:00:27","slug":"rayzebio-stock-opens-with-a-big-gain-to-push-valuation-up-to-1-4-billion","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=12589","title":{"rendered":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion"},"content":{"rendered":"
\n

Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock
\n RYZB,
\n +33.33%<\/bg-quote>
\n opened 38.9% above the initial public offering price. The company had raised $311 million as it sold 17.3 million shares in the IPO, up from an expected 14.4 million shares, with the IPO pricing at $18 a share, at the top of the expected range. The stock\u2019s first trade on the Nasdaq was at $25.00 at 11:38 a.m. Eastern for 629,709 shares. At that price, the company market capitalization was $1.38 billion. RayzeBio\u2019s upbeat debut comes a day after high-profile semiconductor-design company Arm Holdings PLC
\n ARM,
\n -4.47%<\/bg-quote>
\n was also cheered in its debut, with Arm\u2019s stock closing Thursday 24.7% above its IPO price. RayzeBio\u2019s stock has gained ground since it opened, as it was last up 39.6%. The back-to-back upbeat debuts comes as the Renaissance IPO ETF
\n IPO,
\n -0.96%<\/bg-quote>
\n has edged up 0.1% over the past three months while the S&P 500
\n SPX,
\n -1.22%<\/bg-quote>
\n has gained 0.9%.<\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above the initial public offering price. The company had raised $311 million as it sold 17.3 million shares in the IPO, up from an expected 14.4 million shares, with the IPO pricing at $18 a […]<\/p>\n","protected":false},"author":1,"featured_media":3604,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[32],"tags":[],"class_list":{"0":"post-12589","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"yoast_head":"\nRayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds<\/title>\n<meta name=\"description\" content=\"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=12589\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=12589\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-16T15:00:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/MW-GP644_MicroS_ZG_20180906154215.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t<meta property=\"og:image:height\" content=\"742\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=12589#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=12589\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion\",\"datePublished\":\"2023-09-16T15:00:27+00:00\",\"dateModified\":\"2023-09-16T15:00:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=12589\"},\"wordCount\":176,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=12589#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=12589\",\"url\":\"https:\/\/prosfunds.com\/?p=12589\",\"name\":\"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2023-09-16T15:00:27+00:00\",\"dateModified\":\"2023-09-16T15:00:27+00:00\",\"description\":\"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=12589#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=12589\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=12589#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds","description":"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=12589","og_locale":"en_US","og_type":"article","og_title":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds","og_description":"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above","og_url":"https:\/\/prosfunds.com\/?p=12589","og_site_name":"Prosfunds","article_published_time":"2023-09-16T15:00:27+00:00","og_image":[{"width":1320,"height":742,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/MW-GP644_MicroS_ZG_20180906154215.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=12589#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=12589"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion","datePublished":"2023-09-16T15:00:27+00:00","dateModified":"2023-09-16T15:00:27+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=12589"},"wordCount":176,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=12589#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=12589","url":"https:\/\/prosfunds.com\/?p=12589","name":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2023-09-16T15:00:27+00:00","dateModified":"2023-09-16T15:00:27+00:00","description":"Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical company\u2019s stock RYZB, +33.33% opened 38.9% above","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=12589#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=12589"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=12589#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"RayzeBio stock opens with a big gain, to push valuation up to $1.4 billion"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/12589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12589"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/12589\/revisions"}],"predecessor-version":[{"id":12590,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/12589\/revisions\/12590"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/3604"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}